Tirzepatide (mounjaro) pen – 50mg

Tirzepatide (brand names include Mounjaro and Zepbound) is a medication that activates both GIP and GLP-1 receptors. Potential benefits include:
Substantial weight loss in many patients when combined with diet and physical activity.
Improved blood sugar control in people with Type 2 Diabetes.
Reduction in HbA1c levels (a measure of average blood glucose over about 3 months).
Decreased appetite and food cravings, helping some people consume fewer calories.
Increased feelings of fullness (satiety) after meals.
Improved insulin sensitivity, allowing the body to use insulin more effectively.
Potential improvements in cardiovascular risk factors, such as blood pressure, triglycerides, and cholesterol levels.
Once-weekly dosing, which many people find more convenient than daily medications.
May reduce liver fat and improve markers associated with metabolic dysfunction in some patients.
Can help maintain weight loss when treatment is continued, alongside lifestyle changes.